SANA
Income statement / Annual
Last year (2023), Sana Biotechnology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Sana Biotechnology, Inc.'s net income was -$283.26 M.
See Sana Biotechnology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$30.87 M |
$27.73 M |
$17.91 M |
$10.17 M |
$3.92 M |
$1,000.00 |
| Gross Profit |
-$30.87 M |
-$27.73 M |
-$17.91 M |
-$10.17 M |
-$3.92 M |
-$1,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$221.64 M
|
$201.00 M
|
$306.50 M
|
$257.88 M
|
$119.38 M
|
$4.01 M
|
| General & Administrative
Expenses |
$73.30 M
|
$71.56 M
|
$50.41 M
|
$28.27 M
|
$21.78 M
|
$8.41 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$4.21 M
|
| Selling, General &
Administrative Expenses |
$73.30 M
|
$71.56 M
|
$50.41 M
|
$28.27 M
|
$21.78 M
|
$4.21 M
|
| Other Expenses |
$0.00 |
-$674,000.00 |
$305,000.00 |
$97,000.00 |
-$29,000.00 |
$0.00 |
| Operating Expenses |
$294.94 M |
$272.56 M |
$356.91 M |
$286.15 M |
$141.15 M |
$8.22 M |
| Cost And Expenses |
$325.81 M |
$272.56 M |
$356.91 M |
$286.15 M |
$141.15 M |
$8.22 M |
| Interest Income |
$9.94 M |
$3.76 M |
$676,000.00 |
$747,000.00 |
$2.86 M |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$24.56 M
|
$27.73 M
|
$17.91 M
|
$10.17 M
|
$3.92 M
|
$1,000.00
|
| EBITDA |
-$252.39 M
|
-$256.94 M
|
-$356.91 M
|
-$287.03 M
|
-$138.90 M
|
-$13.25 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$43.65 M
|
$3.09 M
|
$981,000.00
|
$844,000.00
|
$2.83 M
|
-$5.03 M
|
| Income Before Tax |
-$283.26 M |
-$269.48 M |
-$355.93 M |
-$285.31 M |
-$138.33 M |
-$13.25 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$3.09 M |
-$11.75 M |
-$6.67 M |
-$7.55 M |
$0.00 |
| Net Income |
-$283.26 M |
-$266.39 M |
-$344.18 M |
-$278.64 M |
-$130.78 M |
-$13.25 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.46 |
-1.41 |
-2.07 |
-1.49 |
-0.7 |
-0.0707 |
| EPS Diluted |
-1.46 |
-1.41 |
-2.07 |
-1.49 |
-0.7 |
-0.0707 |
| Weighted Average Shares
Out |
$194.54 M
|
$188.34 M
|
$166.43 M
|
$187.51 M
|
$187.34 M
|
$187.34 M
|
| Weighted Average Shares
Out Diluted |
$194.54 M
|
$188.34 M
|
$166.43 M
|
$187.51 M
|
$187.34 M
|
$187.34 M
|
| Link |
|
|
|
|
|
|
